Epithelioid angiomyolipoma a morphologically distinct variant that mimics a variety of intra-abdominal neoplasms

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 5, 2011, Pages 665-670

  Mete, Ozgur ^a   Van Der Kwast, Theodorus H ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ABDOMINAL TUMOR; ANGIOMYOLIPOMA; EPITHELIOID CELL; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; REVIEW; SOFT TISSUE TUMOR;

ABDOMINAL NEOPLASMS; ANGIOMYOLIPOMA; EPITHELIOID CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79956301399     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; 2004. World Health Organization Classification of Tumours.
2. Hornick JL, Fletcher CDM. PEComa: what do we know so far? Histopathology. 2006;48(1):75-82.
3. Armah HB, Parwani AV. Perivascular epithelioid cell tumor. Arch Pathol Lab Med. 2009;133(4):648-654.
4. Aydin H, Magi-Galluzzi C, Lane BR, et al. Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association. Am J Surg Pathol. 2009;33(2):289-297.
5. Ito M, Sugamura Y, Ikari H, Sekine I. Angiomyolipoma of the lung. Arch Pathol Lab Med. 1998;122(11):1023-1025. (Pubitemid 28521051)
6. Insabato L, De Rosa G, Terracciano LM, Fazioli F, Di Santo F, Rosai J. Primary monotypic epithelioid angiomyolipoma of bone. Histopathology. 2002; 40(3):286-290. (Pubitemid 34227120)
7. Banerjee SS, Eyden B, Trenholm PW, et al. Monotypic angiomyolipoma of the nasal cavity, a heretofore undescribed occurrence. Int J Surg Pathol. 2001; 9(4):309-315. (Pubitemid 34031148)
8. Martignoni G, Pea M, Bonetti F, et al. Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study. Am J Surg Pathol. 1998;22(6):663-672. (Pubitemid 28280268)
9. McLendon RE, Tien RD. Tuberous sclerosis (Bourneveville's disease). In: Bigner DD, McLendon RE, Bruner JM, eds. Russell and Rubinstein's Pathology of Tumors of the Nervous System. 6th ed. London, England: Arnold; 1998:389-393.
10. Faraji H, Nguyen BN, Mai KT. Renal epithelioid angiomyolipoma: a study of six cases and a meta-analytic study: development of criteria for screening the entity with prognostic significance. Histopathology. 2009;55(5):525-534.
11. Khan AN, Boylan C, MacDonald S, et al. Angiomyolipoma, kidney, http:// emedicine.medscape.com/article/376848-overview. Accessed August 31, 2009.
12. Fletcher CDM, ed. Diagnostic Histopathology of Tumors. 3rd ed. Philadelphia, PA: Churchill Livingstone-Elsevier; 2007.
13. Martignoni G, Pea M, Bonetti F, Brunelli M, Eble JN. Oncocytoma-like angiomyolipoma: a clinicopathologic and immunohistochemical study of 2 cases. Arch Pathol Lab Med. 2002;126(5):610-612. (Pubitemid 34477961)
14. Ma L, Kowalski D, Javed K, Hui P. Atypical angiomyolipoma of kidney in a patient with tuberous sclerosis: a case report with p53 gene mutation analysis. Arch Pathol Lab Med. 2005;129(5):676-679. (Pubitemid 40616973)
15. Kilicaslan I, Gulluoglu MG, Dogan O, Uysal V. Intraglomerular microlesions in renal angiomyolipoma. Hum Pathol. 2000;31(10):1325-1328.
16. Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL, Weiss SW. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005; 29(12):1558-1575.
17. Zavala-Pompa A, Folpe AL, Jimenez RE, et al. Immunohistochemical study of microphthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell carcinoma, and renal and retroperitoneal sarcomas: comparative evaluation with traditional diagnostic markers. Am J Surg Pathol. 2001;25(1):65-70. (Pubitemid 32001834)
18. Jungbluth AA, King R, Fiscel DE, et al. Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas. Appl lmmunohistochem Mol Morphol. 2001;9(1):29-34.
19. Eble JN, Amin MB, Young RH. Epithelioid angiomyolipoma of the kidney: a report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. Am J Surg Pathol. 1997;21(10):1123-1130.
20. Makhlouf HR, Remotti HE, Ishak KG. Expression of KIT (CD117) in angiomyolipoma. Am J Surg Pathol. 2002;26(4):493-497. (Pubitemid 34280123)
21. Colombat M, Boccon-Gibot L, Carton S. An unusual renal angiomyolipoma with morphological lymphangioleiomyomatosis feature and coexpression of oestrogen and progesterone receptors. Virchows Arch. 2002;440(1):102-104. (Pubitemid 34143356)
22. Holm-Nielsen P, Sorensen FB. Renal angiomyolipoma: an ultrastructural investigation of three cases with histogenetic considerations. APMIS Suppl. 1988; 4:37-47. (Pubitemid 19040311)
23. Mete O, Kilicaslan I, Gulluoglu MG, Uysal V. Can renal oncocytoma be differentiated from its renal mimics?: the utility of anti-mitochondrial, caveolin-1, CD63 and cytokeratin 14 antibodies in the differential diagnosis. Virchows Arch. 2005;447(6):938-946. (Pubitemid 41719548)
24. DeLellis RA, Lloyd RV, Heitz PU, Eng C. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004. World Health Organization Classification of Tumours.
25. Bakke M, Zhao L, Hanley NA, Parker KL. SF-I: a critical mediator of steroidogenesis. Mol Cell Endocrinol. 2001;171(1-2):5-7.
26. Wee A. Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics. Appl lmmunohistochem Mol Morphol. 2006;14(3):266-272.
27. Rocca PC, Brunelli M, Gobbo S, et al. Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study. Mod Pathol. 2007;20(7):722-728. (Pubitemid 46933453)
28. Beadling C, Jacobson-Dunlop E, Hodi FS, et al. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res. 2008;14(21):6821-6828.
29. Huo L, Sugimura J, Tretiakova MS, et al. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Hum Pathol. 2005;36(3): 262-268. (Pubitemid 40404009)
30. Astrinidis A, Henske EP. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease. Oncogene. 2005;24(50):74757481.
31. Plank TL, Logginidou H, Klein-Szanto A, Henske EP. The expression of hamartin, the product of the TSCI gene in normal human tissues and in TSCIand TSC2-linked angiomyolipomas. Mod Pathol. 1999;12(5):539-545. (Pubitemid 29230617)
32. The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 1993;75(7:1305-1315.
33. Plank TL, Yeung RS, Henske EP. Hamartin, the product of the tuberous sclerosis 1 (TSCI) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res. 1998;58(21):4766-4770. (Pubitemid 28503664)
34. Bissler JJ, McCormack FX, Young LR, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med. 2008;358(2):140-151.
35. Kawaguchi K, Oda Y, Nakanishi K, et al. Malignant transformation of renal angiomyolipoma: a case report. Am J Surg Pathol. 2002;26(4):523-529. (Pubitemid 34280128)
36. Hadley DA, Bryant LJ, Ruckle HC. Conservative treatment of renal angiomyolipomas in patients with tuberous sclerosis. Clin Nephrol. 2006;65(1): 22-27. (Pubitemid 43091691)
37. Islam A, Ehara T, Kato H, Hayama M, Nishizawa O. Loss of calponin hi in renal angiomyolipoma correlates with aggressive clinical behavior. Urology. 2004;64(3):468-473. (Pubitemid 39200739)